Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-16

Clinical Trial Update: Preventive Approach to Congenital Heart Block With Hydroxychloroquine [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating hydroxychloroquine as a preventive approach to congenital heart block in the context of neonatal lupus; study completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: NYU Langone Health | Conditions: Congenital Heart Block, Neonatal Lupus | Phase 2 | Status: COMPLETED | Results posted: 2020-03-16